课题基金 / 基金详情

Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products

Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products
神经纤维瘤病1型和2型抑癌基因产物的细胞信号转导研究
批准号:
14571319
负责人:
ARAKI Norie
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

ARAKI Norie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The neurofibromatosis type 1 (NF1) and type 2 (NF2) are autosomal dominantly inherited disorders, and strongly associated with development of intracranial tumors including bilateral vestibular schwannomas, meningiomas and gliomas. NF1 and NF2 genes were recently identified on the different locus, and the proteins they encode (termed as neurofibromin for NF1 and merlin for NF2) were found to be no homologies despite of their pathological similarity. To elucidate the biological function of NF1 and NF2 proteins, we analyzed their signal transductions by cellular proteomic and biological strategies. 1)NF1 : Neurofibromin has a domain acting as a GAP and thought to be an important Ras regulator. We identified 35 novel cellular neurofibromin-associating proteins. 14-3-3 was identified as one of the most interesting core candidates of NF1 regulators. The interaction of 14-3-3 is mainly directed to the C-terminal domain (CTD) of neurofibromin, and the cAMP-dependent protein kinase (PKA)-depend … More ent phosphorylation clustered on CTD-Ser (2576, 2578, 2580, 2813) and Thr (2556) is required for the interaction. Interestingly, the increased phosphorylation and association of 14-3-3 negatively regulate the GAP activity of neurofibromin. These findings indicate that PKA phosphorylation followed by 14-3-3 protein and other protein cluster interactions may modulate the biochemical and biological functions of cellular neurofibromin. 2)NF2 ; Cellular binding proteins of merlin were identified as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70 by MAS spec analysis. The N-terminal (19-339) region of merlin is essential for their interaction. Subcellular co-localizations of merlin and PARP were observed mainly in their nuclear region with a nuclear export signal (NES) dependent manner of merlin. This nuclear accumulation increased with cellular DNA damages, whereas PARP gene deficient MEF could not accumulate merlin in their nuclear region, even after the treatments of LMB or bleomycin, These results suggest that merlin is a cytoplasmic-nuclear shuttling protein directed by its NES-dependent transport pathway being associated with PARP. The tumor suppressive function of merlin may be linked to cellular DNA-repair and related signals via the interaction of cellular merlin binding proteins such as PARP and DNA-PKs. Less
期刊论文(68)
专著(0)
科研奖励(0)
会议论文
荒木 令江: "脳神経系変性疾患および神経系腫瘍の病態プロテオミクス"プロテオミクス-方法とその病態解析への応用""現代化学増刊. 42. 102-112 (2002)
荒木丽惠:《脑神经系统退行性疾病和神经系统肿瘤的病理蛋白质组学》《蛋白质组学-病理分析方法及其应用》现代化学特别版.42.102-112(2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
荒木 令江: "脳疾患の発現プロテオミクス解析,"細胞機能解析に向かうプロテオミクス""実験医学. 20(1). 13-22 (2002)
Reie Araki:“脑疾病表达的蛋白质组学分析,”针对细胞功能分析的蛋白质组学,”实验医学。20(1)。13-22 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yunoue, S. et al.: "Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GAP function toward Ras."J. Biol. Chem.. (In press). (2003)
Yunoue, S. 等人:“神经纤维瘤病 I 型肿瘤抑制因子神经纤维蛋白通过其针对 Ras 的 GAP 功能调节神经元分化。”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
荒木令江: "「in vitroラベル法」オンラインLC-MS法による発現プロファイル解析"決定版!プロテオーム解析マニュアル""実験医学別冊. 111-124 (2004)
Reie Araki:“体外标记方法”使用在线LC-MS方法的表达谱分析“权威版!蛋白质组分析手册”“实验医学特别版.111-124(2004)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
26
    Analysis of molecular network on maintenance and differentiation of glioma stem cells
    • 批准号:
      25640068
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      ARAKI Norie
    • 依托单位:
    System development for microquantitative molecular analyses ofglioma stem cells
    • 批准号:
      23659693
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      ARAKI Norie
    • 依托单位:
    Study of the molecular mechanism of neural tumor formation mediatedby NF1 gene deficiency
    • 批准号:
      22390281
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2010
    • 负责人:
      ARAKI Norie
    • 依托单位:
    Analysis of cellular signal transduction via Neurofibromatosis tumor suppressor gene products and development of their clinical targets
    • 批准号:
      19390382
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.9万
    • 财政年份:
      2007
    • 负责人:
      ARAKI Norie
    • 依托单位:
    国内基金
    海外基金
    NF1突变驱动破骨细胞激活和增殖的机制研究及其对先天性胫骨假关节的治疗意义
    • 批准号:
      2026JJ82341
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      周天生
    • 依托单位:
    剪接因子 SF3B1 R625 位突变通过高强度异常剪接 NF1/RASA1/RASA2 偏好性 驱动黑色素瘤发生的机制
    NF1 通过调节巨噬细胞极化介导局部微环境在先天 性胫骨假关节发病过程中的作用机制研究
    • 批准号:
      2024JJ5217
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      朱光辉
    • 依托单位: